xh001
Vaccineexperimental
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Apr 30, 2024 (NCT06353646)
Timeline
2020s
- Jan 1, 2025
Earliest Phase 1 Sponsor(trial)
Mechanism of action
- Tumor antigensImmunity, active
Tumor antigens immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07298200 | Phase 1 | Dec 31, 2025 | Government of China, Nanjing University |
| NCT07114666 | N/A | Aug 18, 2025 | Chinese Academy of Medical Sciences |
| NCT06353646 | N/A | Apr 30, 2024 | Chinese Academy of Medical Sciences, Government of China |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Chinese Academy of Medical Sciences | Academic/Hospital | 2 | 2 | 1 | 2024 |
| Government of China | Government | 2 | 0 | 2 | 2024 |
| Nanjing University | Academic/Hospital | 1 | 1 | 1 | 2025 |
3 organizations
Page 1 / 1